The Syneos Health Podcast
152 Episodes
-
Payer Power, Part 3
Published: 15/07/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 12: COVID-19 and Children
Published: 19/06/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 11: Rare Disease Clinical Trials and COVID-19
Published: 02/06/2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Yelp Ratings for Clinical Trials
Published: 27/05/2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
Published: 15/05/2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Real World Data for Clinical Innovation
Published: 08/05/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 10: Ventilating the COVID-19 Patient
Published: 05/05/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 9: Telemedicine in the Age of COVID-19
Published: 23/04/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 8: Payers and COVID-19
Published: 16/04/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 7: Continuity in Clinical Trials
Published: 02/04/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
Published: 30/03/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 5: Surviving the Ventilator Shortage
Published: 24/03/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 4: Clinical Trials Through Pandemics
Published: 24/03/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 3: Virtual Clinical Trials
Published: 20/03/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 2: The Clinical Experience
Published: 17/03/2020 -
CORONAVIRUS SPECIAL EDITION, Episode 1: The Personal Experience
Published: 13/03/2020 -
Recruiting Patients for Clinical Trials
Published: 06/03/2020 -
Medical Affairs Series, Part Six: Commercial Plus Medical Affairs
Published: 19/02/2020 -
2020 Health Trends: Box Store Healthcare
Published: 05/02/2020 -
Denials, Delays and Deep Discounts in Pharmaceutical Launch
Published: 24/01/2020
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
